Assessing the Effect of an Inpatient Smoking Cessation Brief Intervention Tool on Long-Term Smoking Cessation Rates and Patient Interest for Nicotine Replacement Therapy: A Retrospective Analysis

被引:1
|
作者
Vitangcol, Kathryn [1 ,2 ]
Puljevic, Cheneal [1 ,3 ]
Snoswell, Centaine [1 ,2 ,4 ]
机构
[1] Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia
[2] Univ Queensland, Ctr Online Hlth, Brisbane, Qld, Australia
[3] Univ Queensland, Ctr Res Excellence Achieving Tobacco Endgame, Sch Publ Hlth, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Pharm Dept, Brisbane, Qld, Australia
关键词
Smoking cessation; Hospital inpatient; Nicotine replacement therapy;
D O I
10.1159/000528864
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Smoking cessation among hospital inpatients is essential to reduce risk of surgical complications and all-cause mortality. In the Australian state of Queensland, the Smoking Cessation Clinical Pathway (SCCP), a brief intervention tool, has been used by clinical staff in public hospitals to uniformly support patients to quit smoking since 2015. This study aims to assess the effect of the SCCP on long-term smoking cessation rates recorded in subsequent readmissions, and whether the SCCP as an intervention affects inpatients' interest in nicotine replacement therapy (NRT) during admission and after discharge. Methods: We retrospectively analysed data provided by the Princess Alexandra Hospital (PAH) on patients who self-identified as a current smoker on admission to any ward and were admitted to the PAH between 1st January 2018 and 31st December 2019. Smoking cessation rates and patient interest in NRT by SCCP completion were analysed using chi(2) tests and a multinomial logistic regression. Results: Of 1,902 included patients, NRT was offered to 1,397 patients (73.4%) and accepted by 332 patients (17.5%). Patients who had completed a SCCP were more likely to be offered NRT than those who had not (p < 0.0001). Of the 452 patients with multiple readmissions, 100 (22%) ceased smoking at any point in the 2-year study period. At the end of the 2-year study period, 75 (75%) patients remained abstinent and only 25 (25%) relapsed to smoking as per their final smoking status at the end of the 2-year study period. Patients with a completed SCCP were 1.8 times (RRR: 1.825, p = 0.030) more likely to quit smoking at any point in the 2-year study period, and twice as likely to have quit at the end of the 2-year study period (RRR: 2.064, p = 0.044). Discussion: The SCCP may be effective at increasing smoking cessation rates among hospital inpatients. Future policies promoting long-term smoking cessation should consider implementation of post-discharge follow-up appointments.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 50 条
  • [1] Assessing the effects of an inpatient brief intervention tool for smoking cessation
    Puljevic, Cheneal
    Vitangcol, Kathryn
    De Guzman, Keshia
    Snoswell, Centaine
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S147 - S147
  • [2] Nicotine replacement therapy for long-term smoking cessation: a meta-analysis
    Etter, Jean-Francois
    Stapleton, John A.
    TOBACCO CONTROL, 2006, 15 (04) : 280 - 285
  • [4] Long-term follow-up of nicotine replacement therapy for smoking cessation
    Takagi, Keigo
    Sasamoto, Shuichi
    Hata, Yoshinobu
    Tamaki, Kazuyoshi
    Takahashi, Shoji
    Sato, Fumitomo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S309 - S309
  • [5] Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: A randomized controlled trial
    Scherphof, Charlotte S.
    van den Eijnden, Regina J. J. M.
    Engels, Rutger C. M. E.
    Vollebergh, Wilma A. M.
    DRUG AND ALCOHOL DEPENDENCE, 2014, 140 : 217 - 220
  • [6] Sex differences in long-term smoking cessation rates due to nicotine patch
    Perkins, Kenneth A.
    Scott, John
    NICOTINE & TOBACCO RESEARCH, 2008, 10 (07) : 1245 - 1251
  • [7] Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy
    Franken, FH
    Pickworth, WB
    Epstein, DH
    Moolchan, ET
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) : 154 - 157
  • [8] Which is the best primary medication for long-term smoking cessation - nicotine replacement therapy, bupropion or varenicline?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (17) : 2903 - 2915
  • [9] Gender Differences in Predictors for Long-term Smoking Cessation Following Physician Advice and Nicotine Replacement Therapy
    Monika E. Slovinec D’Angelo
    Robert D. Reid
    K. Stephen Brown
    Andrew L. Pipe
    Canadian Journal of Public Health, 2001, 92 : 418 - 422
  • [10] Gender differences in predictors for long-term smoking cessation following physician advice and nicotine replacement therapy
    D'Angelo, MES
    Reid, RD
    Brown, KS
    Pipe, AL
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2001, 92 (06): : 418 - 422